The medicine 'Salbutamol'. Instructions for use

The drug "Salbutamol" instruction for use refers to the category of bronchodilator funds. Therapeutic dosages of the drug have a pronounced stimulating effect on beta-2-adrenergic receptors in the bronchi, blood vessels and myometrium. "Salbutamol" is produced in tablets, in the form of an aerosol and syrup, as well as a solution for injections and oral administration.

The drug slows over a long period the release of mast cells of leukotrienes, histamine and other active substances. The agent inhibits the late and early reactivity of the bronchi. The drug "Salbutamol" has a pronounced bronchodilator effect, eliminating or preventing bronchospasm. The agent helps to reduce resistance in the respiratory tract, increase the vital capacity in the lungs.

If the recommended therapeutic dosages of the effect on the cardiovascular system are observed, the drug does not. In addition, the "Salbutamol" does not cause an increase in blood pressure. The drug provokes an expansion in the coronary arteries. In addition, the agent has a tocolytic effect (lowers the contractile activity and tone of the myometrium).

When applying non-protracted oral forms of the drug, the onset of its action is noted within thirty minutes. Medicinal forms of prolonged (prolonged) exposure provide the necessary level of the agent in the plasma to maintain therapeutic efficacy for twelve to fourteen hours.

The preparation "Salbutamol" instruction for use recommends taking internally for the elimination or prevention of bronchial asthma (including night), bronchospastic syndrome, COPD.

Parenteral medication is used to eliminate bronchospastic syndrome. Parenteral with the subsequent transition to oral use of the drug "Salbutamol" instruction for use recommends with threatening premature birth with the appearance of contractile activity, insufficiency of isthmico-cervical, fetal bradycardia, operations on the pregnant uterus.

It should be noted that in studies involving animals, the adverse effects of the drug on the fetus have been identified. Adequately controlled studies of the effect of the medication on the state of the pregnant woman and the fetus were not conducted. However, the use of Salbutamol during pregnancy can in some cases be justified, despite the likely risk. The expediency of prescribing a drug to a pregnant patient is determined by her doctor.

Inside, the drug is administered to patients from twelve years a day for three to four times, two to four milligrams each. If necessary, the doctor can increase the dosage to eight milligrams four times a day. The daily dose is not more than thirty-two milligrams.

The drug "Salbutamol" for children from six to twelve years is prescribed for two milligrams no more than four times a day. The maximum dose is twenty-four milligrams a day. Patients from two to six years of one to two milligrams are no more than four times a day.

The drug "Salbutamol" instruction for use does not recommend for hypersensitivity, pregnancy (as a bronchodilator), with lactation.

Solution for the introduction of a vein is not prescribed as a tocolytic in infections in the birth canal, fetal death or fetal malformations, with bleeding against a background of premature detachment or placenta previa. Do not prescribe injections in the first and second trimester with a threatening miscarriage.

Contraindicated drug for children under six years (for the tablet form), children up to two years (for syrup, solution for oral use).

Among the adverse reactions most often noted heartbeat, tachycardia (during pregnancy - in the fetus and the mother), nervous tension, tremor, headache.

Before using Salbutamol, read the instructions and consult with a specialist.